Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-62 in Postherpetic Neuralgia
NCT00809679Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Dec 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of T-62 in postherpetic neuralgia (PHN), sponsored by Pfizer. Started Dec 2008; status: terminated.
02
Drugs
T-62
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00809679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00809679.